文献速递白血病淋巴瘤

无法磷酸化p27Kip1的Y88位点导致p27蛋白水平降低并加速白血病进展

Inability to phosphorylate Y88 of p27Kip1 enforces reduced p27 protein levels and accelerates leukemia progression.
PubMed 文献 · Leukemia · 2022-05-21

该研究构建了Y88被苯丙氨酸替代的p27-Y88F敲入小鼠模型,发现年轻p27-Y88F小鼠体重中度降低,提示p27-Y88F对CDK的抑制作用增强。用v-ABL或BCR::ABL1p190转化时,p27-Y88F原代细胞初始转化受阻,但p27-Y88F小鼠却较野生型更早死于v-ABL诱导的白血病/淋巴瘤,伴v-ABL转化细胞中p27-Y88F水平大幅降低。

要点

  • p27-Y88F敲入小鼠体重中度降低,提示p27-Y88F对CDK抑制增强。
  • p27-Y88F原代细胞经v-ABL或BCR::ABL1p190转化后,祖B细胞集落生长减少。
  • p27-Y88F小鼠较p27野生型小鼠更早死于v-ABL诱导的白血病/淋巴瘤。

核心结论

  • p27-Y88磷酸化参与v-ABL和BCR::ABL1p190诱导的转化,而无法磷酸化Y88导致p27-Y88F蛋白水平降低并加速白血病进展。

研究设计与样本

  • 研究构建了Y88被苯丙氨酸替代的p27-Y88F敲入小鼠模型,并以v-ABL或BCR::ABL1p190进行转化实验。

主要发现

  • 年轻p27-Y88F小鼠出现体重中度降低,提示p27-Y88F对CDK的抑制作用增强。
  • p27-Y88F原代细胞经v-ABL或BCR::ABL1p190转化后,祖B细胞集落生长减少,提示对初始转化不易感。
  • p27-Y88F小鼠较p27野生型动物更早死于v-ABL诱导的白血病/淋巴瘤,伴v-ABL转化细胞中p27-Y88F水平大幅降低。
  • p27-Y88F水平降低似乎为有效细胞增殖所需,并可能支持白血病加速进展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The cyclin-dependent kinase (CDK) inhibitor p27Kip1 regulates cell proliferation. Phosphorylation of tyrosine residue 88 (Y88) converts the inhibitor into an assembly factor and activator of CDKs, since Y88-phosphorylation restores activity to cyclin E,A/CDK2 and enables assembly of active cyclin D/CDK4,6. To investigate the physiological significance of p27 tyrosine phosphorylation, we have generated a knock-in mouse model where Y88 was replaced by phenylalanine (p27-Y88F). Young p27-Y88F mice developed a moderately reduced body weight, indicative for robust CDK inhibition by p27-Y88F. When transformed with v-ABL or BCR::ABL1p190, primary p27-Y88F cells are refractory to initial transformation as evidenced by a diminished outgrowth of progenitor B-cell colonies. This indicates that p27-Y88 phosphorylation contributes to v-ABL and BCR::ABL1p190 induced transformation. Surprisingly, p27-Y88F mice succumbed to premature v-ABL induced leukemia/lymphoma compared to p27 wild type animals. This was accompanied by a robust reduction of p27-Y88F levels in v-ABL transformed cells. Reduced p27-Y88F levels seem to be required for efficient cell proliferation and may subsequently support accelerated leukemia progression. The potent downregulation p27-Y88F levels in all leukemia-derived cells could uncover a novel mechanism in human oncogenesis, where reduced p27 levels are frequently observed.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Jäkel H, Taschler M, Jung K, et al. Inability to phosphorylate Y88 of p27Kip1 enforces reduced p27 protein levels and accelerates leukemia progression. Leukemia. 2022. PMID: 35597806. doi:10.1038/s41375-022-01598-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。